I-Mab Biopharma
IMAB
#9469
Rank
โ‚น4.73 B
Marketcap
โ‚น58.13
Share price
-6.87%
Change (1 day)
-61.87%
Change (1 year)

Revenue for I-Mab Biopharma (IMAB)

Revenue in 2024 (TTM): โ‚น0.29 Billion

According to I-Mab Biopharma's latest financial reports the company's current revenue (TTM ) is โ‚น0.30 Billion. In 2023 the company made a revenue of โ‚น47.16 Million an increase over the revenue in the year 2022 that were of -โ‚น0.4 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for I-Mab Biopharma from 2017 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น0.29 B533.27%
2023 โ‚น47.16 M-111.85%
2022-โ‚น0.4 Billion-314.85%
2021โ‚น0.18 B-94.01%
2020 โ‚น3.09 B5798.4%
2019 โ‚น52.46 M-46.01%
2018 โ‚น97.17 M317.83%
2017โ‚น23.25 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น19.31 M-93.70%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น60.96 B 19,776.95%๐Ÿ‡บ๐Ÿ‡ธ USA